Genentech Expands Holly Springs Investment to $2 Billion, Adding 2,000 Jobs

Genentech announced a major expansion of its planned Holly Springs manufacturing campus, increasing its total East Coast commitment to approximately $2 billion and signaling a long-term bet on Wake County’s biotech workforce. The company said the enlarged site will scale production capacity and focus on next-generation treatments for metabolic conditions, including obesity.

The investment more than doubles an earlier commitment first announced in May 2025 and follows the August 2025 groundbreaking at the Holly Springs site. Genentech stated the facility is expected to be operational by 2029, with construction already underway. Company materials describe the project as Genentech’s first East Coast manufacturing facility and emphasize advanced biomanufacturing, automation and sustainability features.

Genentech outlined job impacts in its expansion description: the project is expected to support more than 2,000 jobs overall, including more than 500 high-wage manufacturing positions that would remain once the plant opens, and more than 1,500 construction jobs during the build-out. The expanded plan adds roughly 100 jobs beyond prior estimates, increasing the scale of both permanent and temporary employment tied to the campus.

State and local leaders welcomed the announcement. North Carolina Governor Josh Stein and North Carolina Secretary of Commerce Lee Lilley praised the investment as strengthening the state’s life sciences sector and advancing job creation. Holly Springs Mayor Mike Kondratick highlighted local planning, workforce and partnership opportunities that the project creates for the town and Wake County.

The Genentech expansion is part of Roche and Genentech’s broader $50 billion U.S. manufacturing and R&D commitment, a signal to the industry that North Carolina remains a competitive location for biomedical production. For Wake County, the combination of advanced manufacturing jobs and large-scale construction spending is likely to boost local payrolls, increase demand for supplier services and support secondary employment in trades, retail and professional services. The firm’s emphasis on automation means the permanent manufacturing roles will skew toward skilled, higher-wage occupations.

Challenges for the region include managing the short-term demands of a large construction workforce and coordinating training pipelines so local residents can access the advertised manufacturing jobs. Holly Springs officials have pointed to planning and workforce partnerships as priorities as the project moves from construction into operations.

For residents of Wake County, the next milestones to watch are construction progress through 2026-2028 and Genentech’s hiring timelines as the firm approaches a 2029 operational target. If the project proceeds as planned, the campus will anchor additional life sciences activity in the region and reshape local labor and supply chains for years to come.